YD Bio YDESW
NASDAQ YDESW
$0.41 -0.06 (-12.77%)
At close: Sep 8, 2026 · 4:00 PM EDT

YD Bio (YDESW) Accounts Payables (2024 - 2026)

YD Bio's (YDESW) quarterly Accounts Payables came in at $371594.0 in Q2 2026, up 813.84% year-over-year from $40663.0 in Q2 2025, and down 10.09% quarter-over-quarter from $413290.0 in Q4 2025.

Analysis

YD Bio (YDESW) Accounts Payables (2024 - 2026) Analysis & Trends

YD Bio (YDESW) has reported Accounts Payables for 3 consecutive years, with $371594.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Accounts Payables rose 813.84% year-over-year to $371594.0 in Q2 2026; TTM through Jun 2026 was $371594.0, a 813.84% increase from a year earlier, with the FY2025 full-year figure at $413290.0, up 1438.34% from the prior year.
  • Accounts Payables was $371594.0 for Q2 2026 at YD Bio, down from $413290.0 in the prior quarter.
  • Over five years, Accounts Payables peaked at $413290.0 in Q4 2025 and troughed at $26866.0 in Q4 2024.
  • A 3-year average of $213103.2 and a median of $206128.5 in 2025 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables surged 1438.34% in 2025 and surged 813.84% in 2026, its largest moves.
  • Over 3 years, Accounts Payables stood at $26866.0 in 2024, then surged by 1438.34% to $413290.0 in 2025, then dropped by 10.09% to $371594.0 in 2026.
  • The last three Accounts Payables figures came in at $371594.0 (Q2 2026), $413290.0 (Q4 2025), and $40663.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn 25.08 Mn
10 YD Bio 29.02 Mn 26.36 Mn - 371,594.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 371,594.00
Dec 31, 2025 413,290.00
Jun 30, 2025 40,663.00
Dec 31, 2024 26,866.00